Platelet Dysfunction and a High Bone Mass Phenotype in a Murine Model of Platelet-Type von Willebrand Disease

Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee

PARFITT, A. M., Drezner, M. K., Glorieux, F. H., Kanis, J. А., Malluche, H. H., Meunier, P. J., Ott, S. M., & Recker, R. R. (1987) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650020617 · Cited by 5,015 · see citing works

Bone Histomorphometry : Standardization of Nomenclature, Symbols, and Units

PARFITT, A. M., Drezner, M. K., Glorieux, F. H., Kanis, J. А., Malluche, H. H., Meunier, P. J., Ott, S. M., & Recker, R. R. (1987) · Journal of Bone and Mineral Research · Cited by 3,258 · see citing works

BIOCHEMISTRY AND GENETICS OF VON WILLEBRAND FACTOR

Sadler, J. E. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.395 · Cited by 1,369 · see citing works

Direct Three-Dimensional Morphometric Analysis of Human Cancellous Bone: Microstructural Data from Spine, Femur, Iliac Crest, and Calcaneus

Hildebrand, T., Laib, A., Müller, R., Dequeker, J., & Ruegsegger, P. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.7.1167 · Cited by 1,303 · see citing works

Structures of Glycoprotein Ibα and Its Complex with von Willebrand Factor A1 Domain

Huizinga, E. G., Tsuji, S., Romijn, R. A., Schiphorst, M. E., de Groot, P. G., Sixma, J. J., & Gros, P. (2002) · Science · doi:10.1126/science.107355 · Cited by 545 · see citing works

Inducible secretion of large, biologically potent von Willebrand factor multimers

Sporn, L. A., Marder, V. J., & Wagner, D. D. (1986) · Cell · doi:10.1016/0092-8674(86)90735-x · Cited by 456 · see citing works

Bone Is a Target for the Antidiabetic Compound Rosiglitazone

Rzońca, S., Suva, L. J., Gaddy, D., Montague, D. C., & Lecka‐Czernik, B. (2003) · Endocrinology · doi:10.1210/en.2003-0746 · Cited by 455 · see citing works

Large Scale Gene Expression Analysis of Osteoclastogenesisin Vitro and Elucidation of NFAT2 as a Key Regulator

Ishida, N., Hayashi, K., Hoshijima, M., Ogawa, T., Koga, S., Miyatake, Y., Kumegawa, M., Kimura, T., & Takeya, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205063200 · Cited by 377 · see citing works

Consequences of GATA-1 Deficiency in Megakaryocytes and Platelets

Vyas, P., Ault, K., Jackson, C. W., Orkin, S. H., & Shivdasani, R. A. (1999) · Blood · doi:10.1182/blood.v93.9.2867.409k24_2867_2875 · Cited by 362 · see citing works

Consequences of GATA-1 Deficiency in Megakaryocytes and Platelets

Vyas, P., Ault, K. A., Jackson, C. W., Orkin, S. H., & Shivdasani, R. A. (1999) · Blood · doi:10.1182/blood.v93.9.2867 · Cited by 357 · see citing works

Direct stimulation of osteoclastic bone resorption by bone morphogenetic protein (BMP)-2 and expression of BMP receptors in mature osteoclasts

Kaneko, H., Arakawa, T., Mano, H., Kaneda, T., Ogasawara, A., Nakagawa, M., Toyama, Y., Yabe, Y., Kumegawa, M., & Hakeda, Y. (2000) · Bone · doi:10.1016/s8756-3282(00)00358-6 · Cited by 347 · see citing works

Rosiglitazone Induces Decreases in Bone Mass and Strength that Are Reminiscent of Aged Bone

Lazarenko, O. P., Rzońca, S., Hogue, W. R., Swain, F. L., Suva, L. J., & Lecka‐Czernik, B. (2007) · Endocrinology · doi:10.1210/en.2006-1587 · Cited by 302 · see citing works

von Willebrand Disease

Nichols, W. C., & Ginsburg, D. B. (1997) · Medicine · doi:10.1097/00005792-199701000-00001 · Cited by 296 · see citing works

Thrombosis and Hemorrhage

Loscalzo, J., & Schafer, A. I. (2002) · Cited by 291 · see citing works

Generation and rescue of a murine model of platelet dysfunction: the Bernard-Soulier syndrome.

Ware, J., Russell, S., & Ruggeri, Z. (2000) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.050582097 · Cited by 290 · see citing works

Hematology

Kwaan, H. C. (2003) · JAMA · doi:10.1001/jama.289.22.3014-b · Cited by 240 · see citing works

Circulating Osteoprotegerin and Receptor Activator for Nuclear Factor κB Ligand: Clinical Utility in Metabolic Bone Disease Assessment

Rogers, A., & Eastell, R. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0794 · Cited by 215 · see citing works

Expression of interleukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis in vivo.

Bendre, M. S., Gaddy-Kurten, D., Mon-Foote, T., Akel, N. S., Skinner, R. A., Nicholas, R. W., & Suva, L. J. (2002) · PubMed · Cited by 212 · see citing works

Bone Morphogenetic Proteins in Bone Stimulate Osteoclasts and Osteoblasts During Bone Development

Okamoto, M., Murai, J., Yoshikawa, H., & Tsumaki, N. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060411 · Cited by 212 · see citing works

Glycoprotein Ib–IX–V

Andrews, R. K., Gardiner, E. E., Shen, Y., Whisstock, J. C., & Berndt, M. C. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00280-7 · Cited by 209 · see citing works

A model of myelofibrosis and osteosclerosis in mice induced by overexpressing thrombopoietin (mpl ligand): reversal of disease by bone marrow transplantation

Yan, X., Lacey, D. L., Hill, D., Chen, Y., Fletcher, F., Hawley, R. G., & Ik, M. (1996) · Blood · doi:10.1182/blood.v88.2.402.bloodjournal882402 · Cited by 202 · see citing works

Platelet-type von Willebrand's disease: characterization of a new bleeding disorder

Miller, J., & Castella, A. (1982) · Blood · doi:10.1182/blood.v60.3.790.790 · Cited by 202 · see citing works

Transcriptional Program of Mouse Osteoclast Differentiation Governed by the Macrophage Colony-stimulating Factor and the Ligand for the Receptor Activator of NFκB

Cappellen, D., Luong-Nguyen, N.-H., Bongiovanni, S., Grenet, O., Wanke, C., & Šuša, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200434200 · Cited by 184 · see citing works

Efficient plasma membrane expression of a functional platelet glycoprotein Ib-IX complex requires the presence of its three subunits.

López, J. A., Leung, B., Reynolds, C. C., Li, C. Q., & Fox, J. E. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42354-x · Cited by 175 · see citing works

Mutation in the gene encoding the alpha chain of platelet glycoprotein Ib in platelet-type von Willebrand disease.

Miller, J. L., Cunningham, D., Lyle, V. A., & Finch, C. N. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.4761 · Cited by 156 · see citing works

Pattern of gene expression following rat tibial marrow ablation

Suva, L. J., Seedor, G., Endo, N., Quartuccio, H. A., Thompson, D. D., Bab, I., & Rodan, G. A. (1993) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650080315 · Cited by 149 · see citing works

Inhibin Suppresses and Activin Stimulates Osteoblastogenesis and Osteoclastogenesis in Murine Bone Marrow Cultures

Gaddy-Kurten, D., Coker, J., Abe, E., Jilka, R. L., & Manolagas, S. C. (2002) · Endocrinology · doi:10.1210/endo.143.1.8580 · Cited by 145 · see citing works

Megakaryocyte-Osteoblast Interaction Revealed in Mice Deficient in Transcription Factors GATA-1 and NF-E2

Kacena, M. A., Shivdasani, R. A., Wilson, K. M., Xi, Y., Troiano, N. W., Nazarian, A., Gundberg, C. M., Bouxsein, M., Lorenzo, J. A., & Horowitz, M. C. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.0301254 · Cited by 136 · see citing works

The use of micro-CT to evaluate cortical bone geometry and strength in nude rats: Correlation with mechanical testing, pQCT and DXA

Bagi, C. M., Hanson, N., Andresen, C. J., Pero, R. W., Lariviere, R., Turner, C. H., & Laib, A. (2005) · Bone · doi:10.1016/j.bone.2005.07.028 · Cited by 135 · see citing works

Dimeric ristocetin flocculates proteins, binds to platelets, and mediates von Willebrand factor-dependent agglutination of platelets

Scott, J. P., Montgomery, R. R., & Retzinger, G. S. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)92954-6 · Cited by 133 · see citing works

Luminographic Detection of von Willebrand Factor Multimers in Agarose Gels and on Nitrocellulose Membranes

Budde, U., Schneppenheim, R., Plendl, H., Dent, J., Ruggeri, Z. M., & Zimmerman, T. S. (1990) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1645215 · Cited by 115 · see citing works

A reciprocal regulatory interaction between megakaryocytes, bone cells, and hematopoietic stem cells

Kacena, M. A., Gundberg, C. M., & Horowitz, M. C. (2006) · Bone · doi:10.1016/j.bone.2006.05.019 · Cited by 114 · see citing works

Inhibin A Is an Endocrine Stimulator of Bone Mass and Strength

Perrien, D. S., Akel, N. S., Edwards, P. K., Carver, A. A., Bendre, M. S., Swain, F. L., Skinner, R. A., Hogue, W. R., Nicks, K. M., Pierson, T. M., et al. (2006) · Endocrinology · doi:10.1210/en.2006-0848 · Cited by 111 · see citing works

Localization of bone morphogenetic proteins (BMPs)-2, -4, and -6 within megakaryocytes and platelets

Sipe, J. B., Zhang, J., Waits, C., Skikne, B., Garimella, R., & Anderson, H. C. (2004) · Bone · doi:10.1016/j.bone.2004.08.020 · Cited by 101 · see citing works

von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease.

Miller, J. L., Kupinski, J. M., Castella, A., & Ruggeri, Z. M. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111112 · Cited by 100 · see citing works

Identification of Essential GATA and Ets Binding Motifs within the Promoter of the Platelet Glycoprotein Ibα Gene

Hashimoto, Y., & Ware, J. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.41.24532 · Cited by 98 · see citing works

Identification and functional characterization of a novel 27-bp deletion in the macroglycopeptide-coding region of the GPIBA gene resulting in platelet-type von Willebrand disease

Othman, M., Notley, C. R. P., Lavender, F. L., White, H., Byrne, C. D., Lillicrap, D., & O’Shaughnessy, D. (2005) · Blood · doi:10.1182/blood-2002-09-2942 · Cited by 88 · see citing works

Impaired megakaryocytopoiesis in type 2B von Willebrand disease with severe thrombocytopenia

Nurden, P., Debili, N., Vainchenker, W., Bobe, R., Bredoux, R., Corvazier, E., Combrié, R., Fressinaud, É., Meyer, D., Nurden, A. T., et al. (2006) · Blood · doi:10.1182/blood-2006-03-009449 · Cited by 87 · see citing works

Megakaryocyte-mediated inhibition of osteoclast development

Kacena, M. A., Nelson, T., Clough, M. E., Lee, S., Lorenzo, J. A., Gundberg, C. M., & Horowitz, M. C. (2006) · Bone · doi:10.1016/j.bone.2006.05.004 · Cited by 83 · see citing works

Bone morphogenetic proteins 5 and 6 stimulate osteoclast generation

Wutzl, A., Brozek, W., Lernbass, I., Rauner, M., Hofbauer, G., Schopper, C., Watzinger, F., Peterlik, M., & Pietschmann, P. (2005) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.30615 · Cited by 74 · see citing works

Platelet-type von Willebrand Disease

Miller, J. L. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650385 · Cited by 71 · see citing works

Aging alters the skeletal response to disuse in the rat

Perrien, D. S., Akel, N. S., Dupont‐Versteegden, E. E., Skinner, R. A., Siegel, E. R., Suva, L. J., & Gaddy, D. (2006) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00302.2006 · Cited by 68 · see citing works

Identification of a point mutation in type IIB von Willebrand disease illustrating the regulation of von Willebrand factor affinity for the platelet membrane glycoprotein Ib-IX receptor.

Ware, J. L., Dent, J. A., Azuma, H., Sugimoto, M., Kyrle, P. A., Yoshioka, A., & Ruggeri, Z. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.7.2946 · Cited by 67 · see citing works

Megakaryocytes modulate osteoblast synthesis of type-l collagen, osteoprotegerin, and RANKL

BORD, S., FRITH, E., IRELAND, D., SCOTT, M., CRAIG, J., & COMPSTON, J. (2005) · Bone · doi:10.1016/j.bone.2004.12.006 · Cited by 63 · see citing works

Alternative expression of platelet glycoprotein Ib(beta) mRNA from an adjacent 5' gene with an imperfect polyadenylation signal sequence.

Zieger, B., Hashimoto, Y., & Ware, J. L. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119188 · Cited by 63 · see citing works

Dysfunctional platelet membrane receptors: from humans to mice

Ware, J. L. (2004) · Thrombosis and Haemostasis · doi:10.1160/th04-05-0308 · Cited by 62 · see citing works

Osteoclast formation and bone resorption are inhibited by megakaryocytes

Beeton, C. A., Bord, S., Ireland, D., & Compston, J. E. (2006) · Bone · doi:10.1016/j.bone.2006.06.004 · Cited by 61 · see citing works

Loss of the transcription factor p45 NF-E2 results in a developmental arrest of megakaryocyte differentiation and the onset of a high bone mass phenotype

Kacena, M. A., Gundberg, C. M., Nelson, T., & Horowitz, M. C. (2005) · Bone · doi:10.1016/j.bone.2004.09.024 · Cited by 58 · see citing works

Molecular Analyses of the Platelet Glycoprotein Ib-IX-V Receptor

Ware, J. L. (1998) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614928 · Cited by 55 · see citing works

Identification of a novel point mutation in platelet glycoprotein Ibα, Gly to Ser at residue 233, in a Japanese family with platelet-type von Willebrand disease

Matsubara, Y., Murata, M., Sugita, K., & Ikeda, Y. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00369.x · Cited by 49 · see citing works

Expression of human platelet glycoprotein Ib alpha in transgenic mice.

Ware, J. L., Russell, S., Marchese, P., & Ruggeri, Z. M. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53105-7 · Cited by 43 · see citing works

Decalcified Bone: Twenty Years of Successful Specimen Management

Skinner, R. A., Hickmon, S. G., Lumpkin, C. K., Aronson, J., & Nicholas, R. W. (1997) · Journal of Histotechnology · doi:10.1179/his.1997.20.3.267 · Cited by 43 · see citing works

Insights into von Willebrand factor proteolysis: clinical implications

Bowen, D. J., & Collins, P. W. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06096.x · Cited by 43 · see citing works

Expression of the phenotypic abnormality of platelet-type von Willebrand disease in a recombinant glycoprotein Ib alpha fragment.

Murata, M., Russell, S., Ruggeri, Z. M., & Ware, J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116438 · Cited by 36 · see citing works

Expression and Functional Characterization of an Abnormal Platelet Membrane Glycoprotein Ibα (Met239 → Val) Reported in Patients With Platelet-Type von Willebrand Disease

Moriki, T., Murata, M., Kitaguchi, T., Anbo, H., Handa, M., Watanabe, K., Takahashi, H., & Ikeda, Y. (1997) · Blood · doi:10.1182/blood.v90.2.698 · Cited by 36 · see citing works

Expression of Bone Morphogenetic Proteins and their Receptors in the Bone Marrow Megakaryocytes of GATA-1 low Mice

Garimella, R., Kacena, M. A., Tague, S. E., Wang, J., Horowitz, M. C., & Anderson, H. C. (2007) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.6a7164.2007 · Cited by 31 · see citing works

In Vivo Expression of Murine Platelet Glycoprotein Ibα

Fujita, H., Hashimoto, Y., Russell, S., Zieger, B., & Ware, J. L. (1998) · Blood · doi:10.1182/blood.v92.2.488 · Cited by 29 · see citing works

The Role of Transcription Factor NF‐E2 in Megakaryocyte Maturation and Platelet Production

Shivdasani, R. A. (1996) · Stem Cells · doi:10.1002/stem.5530140714 · Cited by 20 · see citing works

Bone metastasis: mechanisms and therapeutic opportunities

Suva, L. J., Washam, C. L., Nicholas, R. W., & Griffin, R. J. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.227 · Cited by 423 · see citing works

Metastasis: new functional implications of platelets and megakaryocytes

Leblanc, R., & Peyruchaud, O. (2016) · Blood · doi:10.1182/blood-2016-01-636399 · Cited by 232 · see citing works

Of von Willebrand factor and platelets

Bryckaert, M., Rosa, J., Denis, C. V., & Lenting, P. J. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1743-8 · Cited by 223 · see citing works

Pharmacologic Inhibition of the TGF-β Type I Receptor Kinase Has Anabolic and Anti-Catabolic Effects on Bone

Mohammad, K. S., Chen, C. G., Balooch, G., Stebbins, E. G., McKenna, C. R., Davis, H., Niewolna, M., Peng, X., Nguyen, D. H., Ionova-Martin, S. S., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005275 · Cited by 179 · see citing works

A reliable murine model of bone metastasis by injecting cancer cells through caudal arteries

Kuchimaru, T., Kataoka, N., Nakagawa, K., Isozaki, T., Miyabara, H., Minegishi, M., Kadonosono, T., & Kizaka‐Kondoh, S. (2018) · Nature Communications · doi:10.1038/s41467-018-05366-3 · Cited by 144 · see citing works

Advances in our understanding of the molecular basis of disorders of platelet function

Nurden, A. T., & Nurden, P. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04274.x · Cited by 140 · see citing works

Targeting myostatin/activin A protects against skeletal muscle and bone loss during spaceflight

Lee, S.-J., Lehar, A., Meir, J. U., Koch, C., Morgan, A., Warren, L. E., Rydzik, R., Youngstrom, D. W., Chandok, H., George, J., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2014716117 · Cited by 115 · see citing works

The ADP receptor P2RY12 regulates osteoclast function and pathologic bone remodeling

Su, X., Floyd, D. H., Hughes, A., Xiang, J., Schneider, J. G., Uluçkan, Ö., Heller, E., Deng, H., Zou, W., Craft, C. S., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci38576 · Cited by 104 · see citing works

The secret life of a megakaryocyte: emerging roles in bone marrow homeostasis control

Malara, A., Abbonante, V., Buduo, C. A. D., Tozzi, L., Currao, M., & Balduini, A. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1813-y · Cited by 92 · see citing works

Factor VIII-von Willebrand Factor Complex Inhibits Osteoclastogenesis and Controls Cell Survival

Baud’huin, M., Duplomb, L., Télétchéa, S., Charrier, C., Maillasson, M., Fouassier, M., & Heymann, D. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.030312 · Cited by 89 · see citing works

Immature and mature megakaryocytes enhance osteoblast proliferation and inhibit osteoclast formation

Ciovacco, W. A., Cheng, Y., Horowitz, M. C., & Kacena, M. A. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22456 · Cited by 75 · see citing works

Circulating interleukin-8 levels explain breast cancer osteolysis in mice and humans

Kamalakar, A., Bendre, M. S., Washam, C. L., Fowler, T. W., Carver, A. A., Dilley, J. D., Bracey, J. W., Akel, N. S., Margulies, A. G., Skinner, R. A., et al. (2014) · Bone · doi:10.1016/j.bone.2014.01.015 · Cited by 65 · see citing works

Genetic Regulation of Bone Metabolism in the Chicken: Similarities and Differences to Mammalian Systems

Johnsson, M., Jonsson, K. B., Andersson, L., Jensen, P., & Wright, D. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005250 · Cited by 58 · see citing works

Rapid Loss of Bone Mass and Strength in Mice after Abdominal Irradiation

Jia, D., Gaddy, D., Suva, L. J., & Corry, P. M. (2011) · Radiation Research · doi:10.1667/rr2505.1 · Cited by 57 · see citing works

Sc65-Null Mice Provide Evidence for a Novel Endoplasmic Reticulum Complex Regulating Collagen Lysyl Hydroxylation

Heard, M. E., Besio, R., Weis, M., Rai, J., Hudson, D. M., Dimori, M., Zimmerman, S. M., Kamykowski, J. A., Hogue, W. R., Swain, F. L., et al. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1006002 · Cited by 57 · see citing works

Platelet-Type von Willebrand Disease: New Insights into the Molecular Pathophysiology of a Unique Platelet Defect

Kaur, H., Emsley, J., & Othman, M. (2013) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0033-1353442 · Cited by 56 · see citing works

Low Bone Turnover and Low BMD in Down Syndrome: Effect of Intermittent PTH Treatment

Fowler, T. W., McKelvey, K. D., Akel, N. S., Schilden, J. V., Bacon, A. W., Bracey, J. W., Sowder, T., Skinner, R. A., Swain, F. L., Hogue, W. R., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042967 · Cited by 55 · see citing works

Platelet-Type Von Willebrand Disease: A Rare, Often Misdiagnosed and Underdiagnosed Bleeding Disorder

Othman, M. (2011) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0031-1281030 · Cited by 53 · see citing works

Involvement of integrins α3β1 and α5β1 and glycoprotein IIb in megakaryocyte‐induced osteoblast proliferation

Lemieux, J. M., Horowitz, M. C., & Kacena, M. A. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22468 · Cited by 52 · see citing works

Mechanisms of thrombocytopenia in platelet-type von Willebrand disease

Bury, L., Malara, A., Momi, S., Petito, E., Balduini, A., & Gresele, P. (2019) · Haematologica · doi:10.3324/haematol.2018.200378 · Cited by 48 · see citing works

Platelet-type Von Willebrand disease: Three decades in the life of a rare bleeding disorder

Othman, M. (2011) · Blood Reviews · doi:10.1016/j.blre.2011.03.003 · Cited by 47 · see citing works

Vitamin D Supplementation Protects against Bone Loss Associated with Chronic Alcohol Administration in Female Mice

Mercer, K. E., Wynne, R. A., Lazarenko, O. P., Lumpkin, C. K., Hogue, W. R., Suva, L. J., Chen, J., Mason, A. Z., Badger, T. M., & Ronis, M. J. J. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.197038 · Cited by 47 · see citing works

Loss of RANKL in osteocytes dramatically increases cancellous bone mass in the osteogenesis imperfecta mouse (oim)

Zimmerman, S. M., Heard‐Lipsmeyer, M. E., Dimori, M., Thostenson, J. D., Mannen, E. M., O’Brien, C. A., & Morello, R. (2018) · Bone Reports · doi:10.1016/j.bonr.2018.06.008 · Cited by 40 · see citing works

Regulation of postnatal trabecular bone formation by the osteoblast endothelin A receptor

Clines, G. A., Mohammad, K. S., Grunda, J. M., Clines, K. L., Niewolna, M., McKenna, C. R., McKibbin, C. R., Yanagisawa, M., Suva, L. J., Chirgwin, J. M., et al. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.450 · Cited by 36 · see citing works

A genetically-engineered von Willebrand disease type 2B mouse model displays defects in hemostasis and inflammation

Adam, F., Casari, C., Prévost, N., Kauskot, A., Loubière, C., Legendre, P., Repérant, C., Baruch, D., Rosa, J., Bryckaert, M., et al. (2016) · Scientific Reports · doi:10.1038/srep26306 · Cited by 33 · see citing works

A novel D235Y mutation in the GP1BA gene enhances platelet interaction with von Willebrand factor in an Iranian family with platelet-type von Willebrand disease

Enayat, S., Ravanbod, S., Rassoulzadegan, M., Jazebi, M., Tarighat, S., Ala, F., Emsley, J., & Othman, M. (2012) · Thrombosis and Haemostasis · doi:10.1160/th12-04-0189 · Cited by 33 · see citing works

Sc65 Is a Novel Endoplasmic Reticulum Protein That Regulates Bone Mass Homeostasis

Gruenwald, K., Castagnola, P., Besio, R., Dimori, M., Chen, Y., Akel, N. S., Swain, F. L., Skinner, R. A., Eyre, D. R., Gaddy, D., et al. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2075 · Cited by 32 · see citing works

Visualizing the von Willebrand factor/glycoprotein Ib-IX axis with a platelet-type von Willebrand disease mutation

Guerrero, J. A., Kyei, M., Russell, S., Liu, J., Gartner, T. K., Storrie, B., & Ware, J. L. (2009) · Blood · doi:10.1182/blood-2009-03-210823 · Cited by 30 · see citing works

Pyk2 regulates megakaryocyte-induced increases in osteoblast number and bone formation

Cheng, Y., Hooker, R. A., Nguyen, K., Gerard-O’Riley, R. L., Waning, D. L., Chitteti, B. R., Meijome, T. E., Chua, H. L., Plett, A., Orschell, C. M., et al. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1876 · Cited by 28 · see citing works

Congenital Thrombocytopenia

Kumar, R., & Kahr, W. H. A. (2013) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2013.02.004 · Cited by 27 · see citing works

Loss of Functional NADPH Oxidase 2 Protects Against Alcohol‐Induced Bone Resorption in Female p47phox −/− Mice

Mercer, K. E., Sims, C. R., Yang, C. S., Wynne, R. A., Moutos, C. P., Hogue, W. R., Lumpkin, C. K., Suva, L. J., Chen, J., Badger, T. M., et al. (2013) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12305 · Cited by 25 · see citing works

Inhibin A enhances bone formation during distraction osteogenesis

Perrien, D. S., Nicks, K. M., Liu, L., Akel, N. S., Bacon, A. W., Skinner, R. A., Swain, F. L., Aronson, J., Suva, L. J., & Gaddy, D. (2011) · Journal of Orthopaedic Research® · doi:10.1002/jor.21501 · Cited by 24 · see citing works

Megakaryocyte Diversity in Ontogeny, Functions and Cell-Cell Interactions

Khatib-Massalha, E., & Méndez-Ferrer, S. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.840044 · Cited by 24 · see citing works

Partial Protection by Dietary Antioxidants Against Ethanol‐Induced Osteopenia and Changes in Bone Morphology in Female Mice

Alund, A. W., Mercer, K. E., Pulliam, C. F., Suva, L. J., Chen, J., Badger, T. M., & Ronis, M. J. J. (2016) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13284 · Cited by 23 · see citing works

Hematopoietic Cell Regulation of Osteoblast Proliferation and Differentiation

Bethel, M., Srour, E. F., & Kacena, M. A. (2011) · Current Osteoporosis Reports · doi:10.1007/s11914-011-0048-1 · Cited by 22 · see citing works

PTHrP(12-48) Modulates the Bone Marrow Microenvironment and Suppresses Human Osteoclast Differentiation and Lifespan

Kamalakar, A., Washam, C. L., Akel, N. S., Allen, B. J., Williams, D. K., Swain, F. L., Leitzel, K. E., Lipton, A., Gaddy, D., & Suva, L. J. (2017) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3142 · Cited by 22 · see citing works

Regulation of bone metabolism by megakaryocytes in a paracrine manner

Lee, Y., Kwak, M. K., Moon, S.-A., Choi, Y. J., Baek, J. E., Park, S. Y., Kim, B., Lee, S. H., & Koh, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-59250-6 · Cited by 22 · see citing works

Male mice with elevated C-type natriuretic peptide-dependent guanylyl cyclase-B activity have increased osteoblasts, bone mass and bone strength

Robinson, J. W., Blixt, N. C., Norton, A., Mansky, K. C., Ye, Z., Aparicio, C., Wagner, B. M., Benton, A. M., Warren, G. L., Khosla, S., et al. (2020) · Bone · doi:10.1016/j.bone.2020.115320 · Cited by 22 · see citing works

A Novel Role for Thrombopoietin in Regulating Osteoclast Development in Humans and Mice

Bethel, M., Barnes, C. L. T., Taylor, A. F., Cheng, Y., Chitteti, B. R., Horowitz, M. C., Bruzzaniti, A., Srour, E. F., & Kacena, M. A. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.24943 · Cited by 21 · see citing works

Platelet-type von Willebrand disease update: the disease, the molecule and the animal model

Othman, M., López, J. A., & Ware, J. L. (2011) · Expert Review of Hematology · doi:10.1586/ehm.11.45 · Cited by 20 · see citing works

The role of platelets and megakaryocytes in bone metastasis

Leblanc, R., & Peyruchaud, O. (2016) · Journal of bone oncology · doi:10.1016/j.jbo.2016.02.007 · Cited by 20 · see citing works

GATA‐1 Deficiency Rescues Trabecular but not Cortical Bone in OPG Deficient Mice

Meijome, T. E., Hooker, R. A., Cheng, Y., Walker, W., Horowitz, M. C., Fuchs, R. K., & Kacena, M. A. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.24803 · Cited by 18 · see citing works

NOX4 Deletion in Male Mice Exacerbates the Effect of Ethanol on Trabecular Bone and Osteoblastogenesis

Watt, J. D., Alund, A. W., Pulliam, C. F., Mercer, K. E., Suva, L. J., Chen, J., & Ronis, M. J. J. (2018) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.247262 · Cited by 18 · see citing works

Skeletal toxicity resulting from exposure of growing male rats to coplanar PCB 126 is associated with disruption of calcium homeostasis and the GH-IGF-1 axis and direct effects on bone formation

Ronis, M. J. J., Watt, J. D., Pulliam, C. F., Williams, A. E., Alund, A. W., Haque, E., Gadupudi, G. S., & Robertson, L. W. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02645-w · Cited by 18 · see citing works

Signaling Pathways Involved in Megakaryocyte‐Mediated Proliferation of Osteoblast Lineage Cells

Cheng, Y., Streicher, D. A., Waning, D. L., Chitteti, B. R., Gerard-O’Riley, R. L., Horowitz, M. C., Bidwell, J. P., Pavalko, F. M., Srour, E. F., Mayo, L. D., et al. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24774 · Cited by 17 · see citing works

Thrombocytopathy leading to impaired in vivo haemostasis and thrombosis in platelet type von Willebrand disease

Kaur, H., Corscadden, K., Ware, J. L., & Othman, M. (2016) · Thrombosis and Haemostasis · doi:10.1160/th16-04-0317 · Cited by 17 · see citing works

Sclerostin Antibody Treatment Stimulates Bone Formation to Normalize Bone Mass in Male Down Syndrome Mice

Williams, D. K., Parham, S. G., Schryver, E. M., Akel, N. S., Shelton, R. S., Webber, J. S., Swain, F. L., Schmidt, J., Suva, L. J., & Gaddy, D. (2017) · JBMR Plus · doi:10.1002/jbm4.10025 · Cited by 16 · see citing works

Platelet dysfunction in platelet-type von Willebrand disease due to the constitutive triggering of the Lyn-PECAM1 inhibitory pathway

Bury, L., Falcinelli, E., Mezzasoma, A. M., Guglielmini, G., Momi, S., & Gresele, P. (2021) · Haematologica · doi:10.3324/haematol.2021.278776 · Cited by 16 · see citing works

Platelets increase while serum reduces the differentiation and activity of osteoclasts in vitro

Agis, H., Schröckmair, S., Skorianz, C., Fischer, M. B., Watzek, G., & Gruber, R. (2013) · Journal of Orthopaedic Research® · doi:10.1002/jor.22386 · Cited by 16 · see citing works

Megakaryocyte-Bone Cell Interactions

Kacena, M. A., & Ciovacco, W. A. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-1050-9_4 · Cited by 16 · see citing works

Megakaryocytes promote osteoclastogenesis in aging

Kanagasabapathy, D., Blosser, R. J., Maupin, K. A., Hong, J. M., Alvarez, M. B., Ghosh, J., Mohamad, S., Aguilar‐Perez, A., Srour, E. F., Kacena, M. A., et al. (2020) · Aging · doi:10.18632/aging.103595 · Cited by 14 · see citing works

Low bone mass and impaired fracture healing in mouse models of Trisomy21 (Down syndrome)

Sherman, K. M., Williams, D. K., Welsh, C. A., Cooper, A., Falck, A. R., Huggins, S. S., Bokhari, R. S., Gaddy, D., McKelvey, K. D., Dawson, L., et al. (2022) · Bone · doi:10.1016/j.bone.2022.116471 · Cited by 13 · see citing works

Reactive Oxygen Species Differentially Regulate Bone Turnover in an Age-Specific Manner in Catalase Transgenic Female Mice

Alund, A. W., Mercer, K. E., Suva, L. J., Pulliam, C. F., Chen, J.-R., Badger, T. M., Remmen, H. V., & Ronis, M. J. J. (2016) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.233213 · Cited by 13 · see citing works

Skeletal Toxicity of Coplanar Polychlorinated Biphenyl Congener 126 in the Rat Is Aryl Hydrocarbon Receptor Dependent

Williams, A. E., Watt, J. D., Robertson, L. W., Gadupudi, G. S., Osborn, M. L., Soares, M. J., Iqbal, K., Pedersen, K. B., Shankar, K., Littleton, S., et al. (2020) · Toxicological Sciences · doi:10.1093/toxsci/kfaa030 · Cited by 13 · see citing works

Megakaryocyte Secreted Factors Regulate Bone Marrow Niche Cells During Skeletal Homeostasis, Aging, and Disease

Karnik, S. J., Nazzal, M. K., Kacena, M. A., & Bruzzaniti, A. (2023) · Calcified Tissue International · doi:10.1007/s00223-023-01095-y · Cited by 12 · see citing works

Phenotypic characterization of transgenic mice harboring Nf1+/− or Nf1−/− osteoclasts in otherwise Nf1+/+ background

Alanne, M. H., Siljamäki, E., Peltonen, S. A., Väänänen, K., Windle, J. J., Parada, L. F., Määttä, J. A., & Peltonen, J. T. K. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24088 · Cited by 11 · see citing works

Lnk Deficiency Leads to TPO-Mediated Osteoclastogenesis and Increased Bone Mass Phenotype

Olivos, D. J., Alvarez, M. B., Cheng, Y., Hooker, R. A., Ciovacco, W. A., Bethel, M., McGough, H., Yim, C., Chitteti, B. R., Eleniste, P. P., et al. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25874 · Cited by 11 · see citing works

Megakaryocyte-bone cell interactions: lessons from mouse models of experimental myelofibrosis and related disorders

Stavnichuk, M., & Komarova, S. V. (2021) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00328.2021 · Cited by 10 · see citing works

The impact of aberrant von Willebrand factor-GPIbα interaction on megakaryopoiesis and platelets in humanized type 2B von Willebrand disease model mouse

Kanaji, S., Morodomi, Y., Weiler-Guettler, H., Zarpellon, A., Montgomery, R. R., Ruggeri, Z. M., & Kanaji, T. (2022) · Haematologica · doi:10.3324/haematol.2021.280561 · Cited by 8 · see citing works

Influence of fat/carbohydrate ratio on progression of fatty liver disease and on development of osteopenia in male rats fed alcohol via total enteral nutrition (TEN)

Ronis, M. J. J., Mercer, K. E., Suva, L. J., Vantrease, J., Ferguson, M. E., Hogue, W. R., Sharma, N., Cleves, M. A., Blackburn, M. L., & Badger, T. M. (2014) · Alcohol · doi:10.1016/j.alcohol.2013.12.005 · Cited by 8 · see citing works

Developing an artificial intelligence–generated peptide targeting platelet-type von Willebrand disease

Kazmirchuk, T. D. D., Wang, J., Bury, L., Falcinelli, E., Bradbury-Jost, C., Koziar, A., Al‐gafari, M., Takallou, S., Willmore, W. G., Dehne, F., et al. (2025) · Blood Advances · doi:10.1182/bloodadvances.2025017674 · Cited by 6 · see citing works

Thrombopoietic agents enhance bone healing in mice, rats, and pigs

Childress, P., Nielsen, J. J., Bemenderfer, T. B., Dadwal, U. C., Chakraborty, N., Harris, J. S., Bethel, M., Alvarez, M. B., Tucker, A., Wessel, A. R., et al. (2024) · Journal of Bone and Mineral Research · doi:10.1093/jbmr/zjae191 · Cited by 5 · see citing works

Impact of Alcohol on Bone Health in People Living With HIV : Integrating Clinical Data From Serum Bone Markers With Morphometric Analysis in a Non‐Human Primate Model

Denys, A., Norman, A. R., Perrien, D. S., Suva, L. J., Simon, L., McDaniel, L. S., Ferguson, T. F., Pedersen, K. B., Welsh, D. A., Molina, P. E., et al. (2022) · JBMR Plus · doi:10.1002/jbm4.10703 · Cited by 5 · see citing works

Development of Megakaryocytes

Papadantonakis, N., & Ravid, K. (2009) · Springer eBooks · doi:10.1007/978-0-387-85816-6_5 · Cited by 4 · see citing works

Platelet Disorders

Clemetson, K. J. (2010) · doi:10.1002/9781444318531.ch20 · Cited by 3 · see citing works

Inhibition of Osteoblast Differentiation by JAK2V617F Megakaryocytes Derived From Male Mice With Primary Myelofibrosis

Karagianni, A., Matsuura, S., Gerstenfeld, L. C., & Ravid, K. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.929498 · Cited by 2 · see citing works

Imaging bone blood perfusion: Not just going with the flow

Suva, L. J., & Gaddy, D. (2013) · Bone · doi:10.1016/j.bone.2013.04.014

Megakaryoctye-Bone Cell Interactions: The Role of Gap Junctions, Maturation, and Longevity

Ciovacca, W. A. (2009) · Europe PMC (PubMed Central)

Platelet disorders

Clemetson, K. J. (2019) · doi:10.1002/9781119252863.ch19

Platelets

Ware, J. L., & Corken, A. L. (2015) · Atherosclerosis · doi:10.1002/9781118828533.ch15

Platelet disorders

Clemetson, K. J. (2024) · doi:10.1002/9781394180486.ch18

Hematopoietic Niche Hijacking in Bone Metastases: Roles of Megakaryocytes, Erythroid Lineage Cells, and Perivascular Stromal Subsets

Alkhatib, A. R., Elshimy, Y., Atassi, B., & Mohammad, K. S. (2026) · Biomedicines · doi:10.3390/biomedicines14010161

Designing the Future of Hemostasis

Kazmirchuk, T. D. D., Wang, J., Corbette, J., Hammad, Z. A. A., Othman, M., & Golshani, A. (2026) · Seminars in Thrombosis and Hemostasis · doi:10.1055/a-2885-4368

Platelet Type Von Willebrand Disease – Diagnostic and Therapeutic Challenges

Wiedenhoefer, R., Boeckelmann, D., Glonnegger, H., Oldenburg, J., & Zieger, B. (2026) · Hämostaseologie · doi:10.1055/a-2940-6179

Spleen-derived circulating intercellular adhesion molecule 2 promotes osteosclerosis in chronic myelofibrosis

Aksornthong, S., Tiedemann, K., Welman, M., Mazharian, A., Lordkipanidzé, M., Senis, Y. A., & Komarova, S. V. (2026) · Bone Research · doi:10.1038/s41413-026-00575-9

Hyperfunctional Platelets in a Murine Model of Platelet-Type von Willebrand Disease.

Ware, J. L., Russell, S., Dent, J. A., & Kanaji, T. (2005) · Blood · doi:10.1182/blood.v106.11.737.737 · Cited by 1 · see citing works

The impact of aberrant von Willebrand factor-GPIbα interaction on megakaryopoiesis and platelets in humanized type 2B von Willebrand disease model mouse

Kanaji, S., Morodomi, Y., Weiler-Guettler, H., Zarpellon, A., Montgomery, R. R., Ruggeri, Z. M., & Kanaji, T. (2022) · Haematologica · doi:10.3324/haematol.2021.280561 · Cited by 8 · see citing works

Mechanisms of thrombocytopenia in platelet-type von Willebrand disease

Bury, L., Malara, A., Momi, S., Petito, E., Balduini, A., & Gresele, P. (2019) · Haematologica · doi:10.3324/haematol.2018.200378 · Cited by 48 · see citing works

Morphological Changes of Platelets from Patients with Von Willebrand Disease Types 2B and 3 Suggest That Von Willebrand Factor Intervenes in Platelet Formation from Megakaryocytes.

Nurden, P., Nurden, A. T., Pasquet, J., Enouf, J., Faurie, C., Marca, S. L., Punzo, M., Baronciani, L., & Federici, A. B. (2008) · Blood · doi:10.1182/blood.v112.11.1238.1238 · Cited by 1 · see citing works

Abnormal Large Platelets Are Associated Not Only with von Willebrand Disease (VWD) Type 2B (Including Type 2B/1 New York) but Also with Severe Type 3: A Potential Role for von Willebrand Factor (VWF) in Megakaryocytopoiesis.

Nurden, P., Nurden, A. T., Enouf, J., Marca, S. L., Baronciani, L., & Federici, A. B. (2007) · Blood · doi:10.1182/blood.v110.11.101.101 · Cited by 4 · see citing works